| Turkey | |||
| Chemotherapy for prostate cancer | from AUD $1,438 | from AUD $6,472 | from AUD $8,917 |
Professor Mustafa Solak gained specialised expertise at the MD Anderson Cancer Center in Texas – consistently ranked as one of the world's leading oncology hospitals.
Dr Eda Tanrikulu reached third place nationwide in the Turkish medical specialty exam and now leads international clinical trials for cancer therapies at Anadolu Medical Center.
Professor Sezer Sağlam is a highly senior medical oncologist at Gayrettepe Florence Nightingale Hospital with a focus on complex drug therapies. He holds a professorship in medical oncology and manages treatment protocols for various advanced solid tumours.
Associate Professor Abdullah Sakin is a leading medical oncologist who formerly served as the Head of the Medical Oncology Department at Yuzuncu Yıl University Faculty of Medicine.
Prostate cancer chemotherapy in Turkey is often chosen for its high-density expertise in treating advanced metastatic or castrate-resistant cases. Specialist centres provide access to docetaxel and cabazitaxel, along with PSMA PET-CT imaging for precise tumour monitoring during systemic treatment cycles.
Bookimed Expert Insight: Turkish oncology centres show a high level of specialisation, with 393 clinics serving nearly 2,000 patients in this category. Doctors like Dr. Nail Paksoy at Medipol Bahçelievler University Hospital lead research into PSMA-based tumour burden. This helps optimise chemotherapy timing for the best possible survival outcomes.
Patient Consensus: Chemotherapy in Turkey is a practical solution for patients whose cancer no longer responds to hormone therapy. Patients find the logistical support and airport transfers make travelling for three-week cycles manageable.